Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:49 PM
Ignite Modification Date:
2025-12-24 @ 1:49 PM
NCT ID:
NCT02810795
Eligibility Criteria:
Inclusion Criteria:
* Age 21-75 years
* Stable angina symptoms, suspected or known CAD, and referred for invasive angiography on clinical grounds.
* Ability to provide informed consent
* Ability to perform a 20-30 second breath hold
Exclusion Criteria:
* Hemodynamically and clinically unstable condition (angina at rest, malignant arrhythmias)
* Prior, documented myocardial infarction, other than (procedure related) minor type II myocardial infarction, which includes Q waves on the ECG or evidence of myocardial infarction on prior non-invasive imaging.
* Prior stenting or coronary artery bypass graft surgery
* Significant other cardiovascular conditions affecting the interpretation of MPICT, including, but not limited to: clinical heart failure, IECD (pacemaker/ICD), severe valvular heart disease or prosthetic valves, significant intra-cardiac shunting or other relevant congenital heart disease.
* eGFR\<60 ml/kg/min
* BMI\>30 kg/m2, or weight \>120 kg.
* Atrial fibrillation or other arrhythmia, \>6 ectopic beats / min
* Known or suspected allergy to iodinated contrast medium
* Pregnancy cannot be excluded
* Contra-indications for adenosine: bronchial asthma, second or third degree atrioventricular block, blood pressure \<110/70 mmHg, allergies or severe side effects in the past.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
75 Years
Study:
NCT02810795
Study Brief:
Protocol Section:
NCT02810795